Skip to main content

Driving and Inhibiting Factors of Single Cell Sequencing Market

 


A paradigm shift in the dynamics of the market is expected to be witnessed around 2029 with the introduction of imaging solutions and single cell automated system in full scale. The leading players in the market are undertaking the necessary steps to tackle the shift in dynamics and sustain the competition.

The global single cell sequencing market is divided into two main categories, instruments and consumables. Kits and consumables market share was valued at $727.2 million of the global single cell sequencing market value in 2018. Also, the kits and consumables is expected to witness impressive growth. The sub-segment is expected to grow with a CAGR of 15.67% during the forecast period 2019-2029. This reflects the dependency of single cell sequencing market on consumables, which is expected to continue to grow in the future.

Single cell sequencing workflow is majorly divided into three segments: single cell isolation, single cell preparation, and single cell analysis. Presently, the market is dominated by single cell analysis techniques. Several key players, such as 10x Genomics, Mission Bio, Bio-Rad Laboratories, and Fluidigm Corporation, have systems and platforms for single cell analysis.

The recent advancement in the technologies for single cell analysis and the availability of funding to promote the research on various applications of single cell technology are factors that have enabled the academic and research institutions to invest in various research studies on single cell sequencing.

Labels

Labels:

Comments

Post a Comment

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...
2 comments
Read more

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...
1 comment
Read more

Analyzing the Growth and Expansion of the Neurostimulation Devices Market

The global healthcare economic burden, at present, is primarily characterized by major contributors such as chronic pain and neurological disorders. The annual societal cost for chronic pain and neurological disorders accounted for $635 billion and $789 billion respectively in the U.S., in 2014. Opioids are one of the most preferred medicines for the treatment of chronic pain, however, the side-effects associated with opioids have resulted in a decline in their overall usage and sale. Consequently, the increasing cases of neurological disorders and the need for a novel approach for the treatment of such diseases has led to the advent of neuromodulation technologies. The rapid shift of the healthcare industry toward neurostimulation devices from opioids and other conventional treatment techniques can be attributed to the efficient, safe, and targeted approach of neurostimulation devices. BIS Research recently published a market intelligence report titled “ Global Neurostim...
Post a Comment
Read more